Vistin Pharma ASA (STU:VP4) E10: €0.07 (As of Mar. 2026)


STU:VP4 Vistin Pharma ASA STU:VP4
77 GF Score
Price €1.80
GF Value €2.26
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Vistin Pharma ASA E10?

Vistin Pharma ASA STU:VP4 +0.28% 77 E10 is €0.07 as of Mar. 2026. GuruFocus rates STU:VP4 with a GF Score™ of 77/100 and a GF Value™ of €2.26 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Vistin Pharma ASA's adjusted earnings per share data for the three months ended in Mar. 2026 was €0.043. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.07 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Vistin Pharma ASA's average E10 Growth Rate was 3.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-07), Vistin Pharma ASA's current stock price is €1.795. Vistin Pharma ASA's E10 for the quarter that ended in Mar. 2026 was €0.07. Vistin Pharma ASA's Shiller PE Ratio of today is 25.64.

During the past 13 years, the highest Shiller PE Ratio of Vistin Pharma ASA was 41.03. The lowest was 25.53. And the median was 30.63.


Vistin Pharma ASA  (STU:VP4) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Vistin Pharma ASA's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=1.795/0.07
=25.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Vistin Pharma ASA was 41.03. The lowest was 25.53. And the median was 30.63.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Vistin Pharma ASA E10 Related Terms


Vistin Pharma ASA E10 Historical Data

* Premium members only.

The historical data trend for Vistin Pharma ASA's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vistin Pharma ASA E10 Chart

Vistin Pharma ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.06 0.07

Vistin Pharma ASA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.07 0.06 0.07 0.07

STU:VP4 vs ZTS, UTHR, VTRS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vistin Pharma ASA's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vistin Pharma ASA Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vistin Pharma ASA's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Vistin Pharma ASA's Shiller PE Ratio falls into.


STU:VP4
77GF Score
Vistin Pharma ASA STU:VP4
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vistin Pharma ASA E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vistin Pharma ASA's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.043/141.0300*141.0300
=0.043

Current CPI (Mar. 2026) = 141.0300.

Vistin Pharma ASA Quarterly Data

per share eps CPI Adj_EPS
201606 0.061 103.800 0.083
201609 0.027 104.200 0.037
201612 -0.049 104.400 -0.066
201703 0.025 105.000 0.034
201706 0.035 105.800 0.047
201709 0.020 105.900 0.027
201712 0.344 106.100 0.457
201803 0.035 107.300 0.046
201806 -0.037 108.500 -0.048
201809 -0.007 109.500 -0.009
201812 -0.182 109.800 -0.234
201903 0.004 110.400 0.005
201906 0.001 110.600 0.001
201909 0.135 111.100 0.171
201912 0.009 111.300 0.011
202003 -0.261 111.200 -0.331
202006 0.044 112.100 0.055
202009 0.009 112.900 0.011
202012 0.018 112.900 0.022
202103 0.020 114.600 0.025
202106 0.018 115.300 0.022
202109 0.002 117.500 0.002
202112 0.016 118.900 0.019
202203 -0.035 119.800 -0.041
202206 0.001 122.600 0.001
202209 -0.015 125.600 -0.017
202212 0.036 125.900 0.040
202303 -0.006 127.600 -0.007
202306 0.014 130.400 0.015
202309 0.046 129.800 0.050
202312 0.036 131.900 0.038
202403 0.015 132.600 0.016
202406 0.038 133.800 0.040
202409 0.031 133.700 0.033
202412 0.031 134.800 0.032
202503 0.042 136.100 0.044
202506 0.036 137.800 0.037
202509 0.036 138.500 0.037
202512 0.030 139.100 0.030
202603 0.043 141.030 0.043

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €0.07 mean?
Vistin Pharma ASA (STU:VP4) has a E10 of €0.07 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Vistin Pharma ASA and its competitors.
Is Vistin Pharma ASA's E10 too high?
Vistin Pharma ASA's current E10 is €0.07. Overall, Vistin Pharma ASA has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vistin Pharma ASA's E10 compare to ZTS and UTHR?
Vistin Pharma ASA's E10 of €0.07 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Vistin Pharma ASA and its competitors. Vistin Pharma ASA's current E10 is €0.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vistin Pharma ASA stock overvalued right now?
Based on GuruFocus' analysis, Vistin Pharma ASA (STU:VP4) is currently considered Modestly Undervalued. The stock's GF Value™ is €2.26, compared to a current price of €1.80 — trading 20.6% below its estimated fair value. The current E10 is €0.07. Vistin Pharma ASA's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Vistin Pharma ASA (STU:VP4), the current E10 is €0.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vistin Pharma ASA (STU:VP4) Overvalued in 2026?

Based on GuruFocus' analysis, Vistin Pharma ASA stock appears to be undervalued. The current stock price of €1.80 is trading 20.6% below its estimated GF Value™ of €2.26. GuruFocus considers Vistin Pharma ASA to be Modestly Undervalued.

Key valuation signals for STU:VP4:

  • E10: €0.07
  • GF Value™: €2.26 vs. price of €1.80 (20.6% below fair value)
  • GF Score™: 77/100 with 3 warning signs

No single metric tells the full story. See the STU:VP4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vistin Pharma ASA Business Description

Address Ostensjoveien 27, P.O. Box 6735 Etterstad, Oslo, NOR, 0661
Vistin Pharma ASA is a pharmaceutical company engaged in the production and supply of active pharmaceutical ingredients (APIs). The company operates in one business segment, Pharmaceuticals, and is a supplier of Metformin, which is used as a standard treatment for Type 2 diabetes. The company generates revenue across multiple geographic regions, including Africa, Europe, Asia, and North and South America.
77GF Score

Get the complete analysis for STU:VP4

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.80
Price
€2.26
GF Value